We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITI
3751
DELISTED
Iteris, Inc.
ITI
$24K ﹤0.01%
3,962
-4,737
-54% -$30.2K
KDNY
3752
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$24K ﹤0.01%
1,564
-2,670
-63% -$43.5K
CMPI
3753
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$24K ﹤0.01%
1,976
+650
+49% +$9.24K
SLCT
3754
DELISTED
Select Bancorp, Inc.
SLCT
$24K ﹤0.01%
2,147
-2,294
-52% -$24.4K
ALTA
3755
DELISTED
Altabancorp
ALTA
$24K ﹤0.01%
560
-3,858
-87% -$136K
AT
3756
DELISTED
Atlantic Power Corporation
AT
$24K ﹤0.01%
8,260
-45,441
-85% -$127K
IPHI
3757
DELISTED
INPHI CORPORATION
IPHI
$24K ﹤0.01%
136
-10,818
-99% -$1.81M
GNCA
3758
DELISTED
Genocea Biosciences, Inc.
GNCA
$24K ﹤0.01%
8,902
-5,991
-40% -$17.7K
LUNA
3759
DELISTED
Luna Innovations Incorporated
LUNA
$24K ﹤0.01%
2,293
-897
-28% -$10K
IHC
3760
DELISTED
Independence Holding Company
IHC
$24K ﹤0.01%
612
-1,315
-68% -$53.6K
INBX
3761
DELISTED
Inhibrx, Inc. Common Stock
INBX
$24K ﹤0.01%
1,188
+414
+53% +$12.1K
ARCC icon
3762
Ares Capital
ARCC
$14.3B
$23K ﹤0.01%
1,240
-5,849
-83% -$105K
BRT
3763
BRT Apartments
BRT
$268M
$23K ﹤0.01%
1,367
-2,799
-67% -$45.6K
CBFV icon
3764
CB Financial Services
CBFV
$192M
$23K ﹤0.01%
1,044
-480
-31% -$9.88K
CODX
3765
Co-Diagnostics
CODX
$5.45M
$23K ﹤0.01%
79
-198
-71% -$79K
CWBC
3766
Community West Bancshares
CWBC
$706M
$23K ﹤0.01%
1,243
-3,639
-75% -$63.5K
DBO icon
3767
Invesco DB Oil Fund
DBO
$387M
$23K ﹤0.01%
2,200
+2,100
+2,100% +$21.2K
EDV icon
3768
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
$23K ﹤0.01%
+187
New +$25.5K
EQX icon
3769
Equinox Gold
EQX
$13.1B
$23K ﹤0.01%
2,933
-25,939
-90% -$240K
EVC icon
3770
Entravision Communication
EVC
$820M
$23K ﹤0.01%
5,596
-29,187
-84% -$101K
FRBA icon
3771
First Bank
FRBA
$471M
$23K ﹤0.01%
1,873
-5,480
-75% -$59.3K
GNK icon
3772
Genco Shipping & Trading
GNK
$1.1B
$23K ﹤0.01%
2,333
-1,781
-43% -$17.2K
GNTY
3773
DELISTED
Guaranty Bancshares
GNTY
$23K ﹤0.01%
618
-2,727
-82% -$86.7K
GSBD icon
3774
Goldman Sachs BDC
GSBD
$1.08B
$23K ﹤0.01%
1,190
-181
-13% -$3.39K
HDSN
3775
Hudson Technologies
HDSN
$236M
$23K ﹤0.01%
14,480
+9,639
+199% +$14K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.